AI
| Followers | 1106 |
| Posts | 279775 |
| Boards Moderated | 10 |
| Alias Born | 03/18/2011 |
Monday, February 25, 2013 10:58:26 AM
$RBCC ~ Investment Highlights
RBCC has acquired a new equity interest in Nano3D Biosciences, Inc. (n3D).
n3D's nanoparticle technology could completely revolutionize cell research.
RBCC is spearheading the most innovative scientific and medical breakthroughs in the $84.6 billion global biotech industry.
U.S. biotech companies raised $25 billion in 2010--a 15-percent jump over the previous year's investment total, according to Ernst & Young.
RBCC is joining the ranks of bioscience companies like Puma-a company that recently announced a private placement of 14.7 million shares of its common stock to investors, resulting in proceeds of $55 million.
Website: http://www.rainbowbiosciences.com/
News: http://finance.yahoo.com/q/h?s=RBCC+Headlines
Chart: http://stockcharts.com/c-sc/sc?s=RBCC&p=D&b=6&g=0&i=p06992661192&r=1357308156063
RBCC has acquired a new equity interest in Nano3D Biosciences, Inc. (n3D).
n3D's nanoparticle technology could completely revolutionize cell research.
RBCC is spearheading the most innovative scientific and medical breakthroughs in the $84.6 billion global biotech industry.
U.S. biotech companies raised $25 billion in 2010--a 15-percent jump over the previous year's investment total, according to Ernst & Young.
RBCC is joining the ranks of bioscience companies like Puma-a company that recently announced a private placement of 14.7 million shares of its common stock to investors, resulting in proceeds of $55 million.
Website: http://www.rainbowbiosciences.com/
News: http://finance.yahoo.com/q/h?s=RBCC+Headlines
Chart: http://stockcharts.com/c-sc/sc?s=RBCC&p=D&b=6&g=0&i=p06992661192&r=1357308156063
Do your DD! Spend only the money you can afford to lose, while still willing to play at other tables. Commissions are cheaper than losses!
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
